Cite
HARVARD Citation
Wu, J. et al. (2018). Anti‐inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis. Journal of the European Academy of Dermatology and Venereology. pp. 1320-1326. [Online].